Document is current
Any future updates will be listed below
-
Authors
Jeanclos, Elisabeth https://orcid.org/0000-0001-5934-5490
Schlötzer, Jan
Hadamek, Kerstin
Yuan-Chen, Natalia https://orcid.org/0000-0001-5152-4670
Alwahsh, Mohammad
Hollmann, Robert
Fratz, Stefanie
Yesilyurt-Gerhards, Dilan
Frankenbach, Tina
Engelmann, Daria
Keller, Angelika
Kaestner, Alexandra
Schmitz, Werner https://orcid.org/0000-0003-0485-7303
Neuenschwander, Martin https://orcid.org/0000-0002-3114-7975
Hergenröder, Roland
Sotriffer, Christoph https://orcid.org/0000-0003-4713-4068
von Kries, Jens Peter
Schindelin, Hermann https://orcid.org/0000-0002-2067-3187
Gohla, Antje https://orcid.org/0000-0002-7442-1487
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB688, FZ82)
Bundesministerium für Bildung und Forschung (01KU1216I)
- License Information
-
More Information
Article History
Received: 27 February 2022
Accepted: 14 October 2022
First Online: 11 November 2022
Competing interests
: The University of Würzburg has filed a patent application relating to the use of compounds described in this work for the treatment of cancer (patent application pending), with A.G. named as inventor. The other authors declare no competing interests.
